Coexisting venous thromboembolism in patients with tuberculosis

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages 478-480

  Sharif Kashani, Babak ^a   Bikdeli, Behnood ^a   Moradi, Ahmadreza ^a,b   Tabarsi, Payam ^b   Chitsaz, Ehsan ^b   Shemirani, Shahrzad ^a   Esmaili Khansari, Mehdi ^a   Masjedi, Mohammad Reza ^c,d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEMOPTYSIS; HOSPITALIZATION; HUMAN; IRAN; LEG EDEMA; LEG PAIN; LETTER; LUNG EMBOLISM; LUNG TUBERCULOSIS; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SPUTUM SMEAR; SURVIVAL TIME; THORAX PAIN; TUBERCULOSIS; TUBERCULOUS PLEURISY; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TUBERCULOSIS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77951974397     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.01.014     Document Type: Letter

References (12)

1. WHO. The world health report 2004: changing history (2004), World Health Organization, Geneva
2. Alikhan R., Cohen A.T., Combe S., et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Analysis of the MEDENOX Study. Arch Intern Med 164 (2004) 963-968
3. Robson S.C., White N.W., Aronson I., Woollgar R., Goodman H., and Jacobs P. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol 93 (1996) 943-949
4. Turken O., Kunter E., Sezer M., et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 6 (2002) 927-932
5. Ambrosetti M., Ferrarese M., Codecasa L.R., et al. For the AIPO/SMIRA TB Study Group. Incidence of venous thromboembolism in tuberculosis patients. Respiration 73 (2006) 396
6. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 381S-453S
7. World Health Organization Stop TB Strategy, accessed on December, 28, 2009. Available at: http://www.who.int/tb/dots/whatisdots/en/index2.html.
8. Samama M.M., Cohen A.T., Darmon J.Y., et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 341 (1999) 793-800
9. Leizorovicz A., Cohen A.T., Turpie A.G., Olsson C.G., Vaitkus P.T., and Goldhaber S.Z. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 17 110 (2004) 874-9
10. Cohen A.T., Davidson B.L., Gallus A.S., et al. ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332 (2006) 325-9
11. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., and Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 367 (2006) 1075-1079
12. White N.W. Venous thrombosis and rifampicin. Lancet 192 (1989) 434-435